LIPID CONTROL IN PATIENTS AFTER MYOCARDIAL INFARCTION - AN EFFECTIVE TOOL FOR MANAGING CARDIOVASCULAR RISKS

The review article highlights the views reflected in the recent clinical guidelines related to high-intensity statin treatment and non statin cholesterol lowering drugs in patients with very high cardiovascular risk after myocardial infarction and the purpose of therapy. The article tells about the...

Full description

Bibliographic Details
Main Authors: O. L. Barbarash, V. V. Kashtalap
Format: Article
Language:Russian
Published: «REMEDIUM GROUP» Ltd. 2017-05-01
Series:Атеротромбоз
Subjects:
Online Access:https://www.aterotromboz.ru/jour/article/view/112
_version_ 1826572497215029248
author O. L. Barbarash
V. V. Kashtalap
author_facet O. L. Barbarash
V. V. Kashtalap
author_sort O. L. Barbarash
collection DOAJ
description The review article highlights the views reflected in the recent clinical guidelines related to high-intensity statin treatment and non statin cholesterol lowering drugs in patients with very high cardiovascular risk after myocardial infarction and the purpose of therapy. The article tells about the approaches to controlling lipidogramic parameters after high-intensity statin therapy was prescribed and to the prescription of PCSK9 inhibitors (Alirocumab) after an acute coronary event. The report was compiled on the basis of the available materials from the national and foreign databases (e-Library, Library’s MEDLINE/PubMed database).
first_indexed 2024-04-10T03:59:20Z
format Article
id doaj.art-4fe8d4a58c7a4e9dacd326ddd93df1b6
institution Directory Open Access Journal
issn 2307-1109
2658-5952
language Russian
last_indexed 2025-03-14T12:27:57Z
publishDate 2017-05-01
publisher «REMEDIUM GROUP» Ltd.
record_format Article
series Атеротромбоз
spelling doaj.art-4fe8d4a58c7a4e9dacd326ddd93df1b62025-03-02T09:27:27Zrus«REMEDIUM GROUP» Ltd.Атеротромбоз2307-11092658-59522017-05-01019410410.21518/2307-1109-2017-1-94-104106LIPID CONTROL IN PATIENTS AFTER MYOCARDIAL INFARCTION - AN EFFECTIVE TOOL FOR MANAGING CARDIOVASCULAR RISKSO. L. Barbarash0V. V. Kashtalap1Research Institute for Complex Issues of Cardiovascular Diseases; Kemerovo State Medical University, MoH RFResearch Institute for Complex Issues of Cardiovascular Diseases: Kemerovo State Medical University, MoH RFThe review article highlights the views reflected in the recent clinical guidelines related to high-intensity statin treatment and non statin cholesterol lowering drugs in patients with very high cardiovascular risk after myocardial infarction and the purpose of therapy. The article tells about the approaches to controlling lipidogramic parameters after high-intensity statin therapy was prescribed and to the prescription of PCSK9 inhibitors (Alirocumab) after an acute coronary event. The report was compiled on the basis of the available materials from the national and foreign databases (e-Library, Library’s MEDLINE/PubMed database).https://www.aterotromboz.ru/jour/article/view/112myocardial infarctionstatinsezetimibepcsk9 inhibitorsalirocumab
spellingShingle O. L. Barbarash
V. V. Kashtalap
LIPID CONTROL IN PATIENTS AFTER MYOCARDIAL INFARCTION - AN EFFECTIVE TOOL FOR MANAGING CARDIOVASCULAR RISKS
Атеротромбоз
myocardial infarction
statins
ezetimibe
pcsk9 inhibitors
alirocumab
title LIPID CONTROL IN PATIENTS AFTER MYOCARDIAL INFARCTION - AN EFFECTIVE TOOL FOR MANAGING CARDIOVASCULAR RISKS
title_full LIPID CONTROL IN PATIENTS AFTER MYOCARDIAL INFARCTION - AN EFFECTIVE TOOL FOR MANAGING CARDIOVASCULAR RISKS
title_fullStr LIPID CONTROL IN PATIENTS AFTER MYOCARDIAL INFARCTION - AN EFFECTIVE TOOL FOR MANAGING CARDIOVASCULAR RISKS
title_full_unstemmed LIPID CONTROL IN PATIENTS AFTER MYOCARDIAL INFARCTION - AN EFFECTIVE TOOL FOR MANAGING CARDIOVASCULAR RISKS
title_short LIPID CONTROL IN PATIENTS AFTER MYOCARDIAL INFARCTION - AN EFFECTIVE TOOL FOR MANAGING CARDIOVASCULAR RISKS
title_sort lipid control in patients after myocardial infarction an effective tool for managing cardiovascular risks
topic myocardial infarction
statins
ezetimibe
pcsk9 inhibitors
alirocumab
url https://www.aterotromboz.ru/jour/article/view/112
work_keys_str_mv AT olbarbarash lipidcontrolinpatientsaftermyocardialinfarctionaneffectivetoolformanagingcardiovascularrisks
AT vvkashtalap lipidcontrolinpatientsaftermyocardialinfarctionaneffectivetoolformanagingcardiovascularrisks